News & Events

Latest News View All

From 40 Billion Molecules to Druggable Potential

Targeted protein degradation (TPD) is moving beyond traditional E3 ligases such as CRBN and VHL, with growing interest in identifying novel E3 ligases. To support...

Mass Spectrometry-based Bioanalysis Platform

As pipeline molecules become increasingly complex, traditional ligand-binding assays may not always provide the level of characterization required. WuXi Biology’s Mass Spectrometry-based Bioanalysis Platform delivers...

From Discovery to IND: A Biology-First Approach to New Modalities:

As therapeutic modalities continue to expand beyond small molecules and monoclonal antibodies, one principle is becoming increasingly important in drug discovery: modality should follow biology....